Skip to Content

Bristol-Myers Squibb

Georges Gobet—AFP/Getty Images
  • Previous Rank145
  • Revenues ($M)$22,561.0
  • Revenue Percent Change8.6%
  • Profits ($M)$4,920.0
  • Profits Percent Change388.6%
  • Assets ($M)$34,986.0
  • Employees23,300

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, psychiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

Giovanni Caforio
CEO Title
Chairman & Chief Executive Officer
Health Care
HQ Location
New York, N.Y.
Years on Fortune 500 List65

Bristol-Myers Squibb Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,561.08.6%
Profits ($M)$4,920.0388.6%
Assets ($M)$34,986.0-
Total Stockholder Equity ($M)$14,031.0-

Profit Ratios

Profit as % of Revenues21.8%
Profits as % of Assets14.1%
Profits as % of Stockholder Equity35.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.01
EPS % Change (from 2017)393.4%
EPS % Change (5 year annual rate)14.3%
EPS % Change (10 year annual rate)1.4%

Total Return

Total Return to Investors (2018)-12.7%
Total Return to Investors (5 year, annualized)2.2%
Total Return to Investors (10 year, annualized)12.3%